BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 19075261)

  • 1. Anticipation in lynch syndrome: still waiting for the answer.
    Gruber SB; Mukherjee B
    J Clin Oncol; 2009 Jan; 27(3):326-7. PubMed ID: 19075261
    [No Abstract]   [Full Text] [Related]  

  • 2. Role for genetic anticipation in Lynch syndrome.
    Nilbert M; Timshel S; Bernstein I; Larsen K
    J Clin Oncol; 2009 Jan; 27(3):360-4. PubMed ID: 19075283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in lynch syndrome.
    Church J; Kravochuck S
    Dis Colon Rectum; 2015 May; 58(5):e77; quiz e79. PubMed ID: 25850851
    [No Abstract]   [Full Text] [Related]  

  • 4. A parametric model for analyzing anticipation in genetically predisposed families.
    Larsen K; Petersen J; Bernstein I; Nilbert M
    Stat Appl Genet Mol Biol; 2009; 8():Article26. PubMed ID: 19492984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of surgery in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer (Lynch syndrome).
    Smith KD; Rodriguez-Bigas MA
    Surg Oncol Clin N Am; 2009 Oct; 18(4):705-15. PubMed ID: 19793576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fertility and apparent genetic anticipation in Lynch syndrome.
    Stupart D; Win AK; Jenkins M; Winship IM; Goldberg P; Ramesar R
    Fam Cancer; 2014 Sep; 13(3):369-74. PubMed ID: 24677027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum.
    Mongiat-Artus P
    Eur Urol; 2008 Dec; 54(6):1235-6. PubMed ID: 18715693
    [No Abstract]   [Full Text] [Related]  

  • 8. Mononucleotide precedes dinucleotide repeat instability during colorectal tumour development in Lynch syndrome patients.
    Ferreira AM; Westers H; Sousa S; Wu Y; Niessen RC; Olderode-Berends M; van der Sluis T; Reuvekamp PT; Seruca R; Kleibeuker JH; Hollema H; Sijmons RH; Hofstra RM
    J Pathol; 2009 Sep; 219(1):96-102. PubMed ID: 19521971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum.
    Burger M
    Eur Urol; 2008 Dec; 54(6):1236. PubMed ID: 18715704
    [No Abstract]   [Full Text] [Related]  

  • 10. Lynch syndrome in women less than 50 years of age with endometrial cancer.
    Walsh MD; Young J; Spurdle A; Obermair A
    Obstet Gynecol; 2008 Oct; 112(4):943. PubMed ID: 18827140
    [No Abstract]   [Full Text] [Related]  

  • 11. High frequency of exon deletions and putative founder effects in French Canadian Lynch syndrome families.
    Chong G; Jarry J; Marcus V; Thiffault I; Winocour S; Monczak Y; Drouin R; Latreille J; Australie K; Bapat B; Gordon PH; Giguère Y; Gologan A; Galiatsatos P; Jass JR; Wong N; Zaor S; Palma L; Kasprzak L; Tischkowitz M; Foulkes WD
    Hum Mutat; 2009 Aug; 30(8):E797-812. PubMed ID: 19459153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic testing in gastroenterology: Lynch syndrome.
    Grover S; Syngal S
    Best Pract Res Clin Gastroenterol; 2009; 23(2):185-96. PubMed ID: 19414145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Lynch syndrome in consecutive patients with colorectal cancer.
    Green RC; Parfrey PS; Woods MO; Younghusband HB
    J Natl Cancer Inst; 2009 Mar; 101(5):331-40. PubMed ID: 19244167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hereditary nonpolyposis colorectal cancer].
    Plevová P; Novotný J; Sachlová M; Krepelová A; Foretová L
    Klin Onkol; 2009; 22 Suppl():S12-5. PubMed ID: 19764386
    [No Abstract]   [Full Text] [Related]  

  • 15. Commentary: The shifting role of family history in Lynch syndrome diagnosis.
    Lynch HT; Shaw TG
    Colorectal Dis; 2009 Jun; 11(5):461-3. PubMed ID: 19508539
    [No Abstract]   [Full Text] [Related]  

  • 16. Hereditary non-polyposis colorectal cancer or Lynch syndrome: the gynaecological perspective.
    Manchanda R; Menon U; Michaelson-Cohen R; Beller U; Jacobs I
    Curr Opin Obstet Gynecol; 2009 Feb; 21(1):31-8. PubMed ID: 19125001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations.
    Barrow E; Robinson L; Alduaij W; Shenton A; Clancy T; Lalloo F; Hill J; Evans DG
    Clin Genet; 2009 Feb; 75(2):141-9. PubMed ID: 19215248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Underutilization of microsatellite instability analysis in colorectal cancer patients at high risk for Lynch syndrome.
    Van Lier MG; De Wilt JH; Wagemakers JJ; Dinjens WN; Damhuis RA; Wagner A; Kuipers EJ; Van Leerdam ME
    Scand J Gastroenterol; 2009; 44(5):600-4. PubMed ID: 19153873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.
    Topping DL; Bird AR; Young GP
    N Engl J Med; 2009 Apr; 360(14):1462; author reply 1462-3. PubMed ID: 19348022
    [No Abstract]   [Full Text] [Related]  

  • 20. Guidelines on genetic evaluation and management of Lynch syndrome.
    Dinjens WN; Dubbink HJ; Wagner A
    Am J Gastroenterol; 2015 Jan; 110(1):192-3. PubMed ID: 25567172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.